| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| D004317 | Doxorubicin | KAZN protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747 
 | 
| D016685 | Mitomycin | KAZN protein affects the susceptibility to Mitomycin | affects response to substance | 16217747 
 | 
| D020849 | Raloxifene | [Raloxifene co-treated with ESR2 protein] results in decreased expression of KAZN mRNA | affects cotreatment|decreases expression | 19059307 
 | 
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of KAZN mRNA | affects cotreatment|decreases expression | 19059307 
 | 
| D014501 | Uranium | Uranium affects the expression of KAZN mRNA | affects expression | 15672453 
 | 
| C005460 | uranyl acetate | uranyl acetate affects the expression of KAZN mRNA | affects expression | 15672453 
 | 
| D014747 | Vinblastine | KAZN protein affects the susceptibility to Vinblastine | affects response to substance | 16217747 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000008 | Abdominal Neoplasms |  | Tamoxifen | 4.99 | 14745880 | 
| MESH:D000230 | Adenocarcinoma |  | Doxorubicin | 2.62 | 17418594 | 
| MESH:D000419 | Albuminuria |  | Doxorubicin | 12.58 | 21441931 | 
| MESH:D000419 | Albuminuria |  | Raloxifene | 12.58 | 17308373	17451421 | 
| MESH:D000544 | Alzheimer Disease |  | Raloxifene | 2.59 | 15800139 | 
| MESH:D019046 | Bone Marrow Neoplasms |  | Doxorubicin | 5.14 | 14601052 | 
| MESH:D001930 | Brain Injuries |  | Raloxifene | 4.83 | 16580743 | 
| MESH:D001932 | Brain Neoplasms |  | Doxorubicin | 4.07 | 17150277 | 
| MESH:D001943 | Breast Neoplasms |  | Doxorubicin | 2.00 | 18628466	16595493	16096432	16115903	18695136	15634643	19526202	16322301	16264153	15994142	15136595	17426702	15939500	15567936	15668708	18382427	16826403	17983394	16935488	17369602	15692762	11325840	15993339	18234424 | 
| MESH:D001943 | Breast Neoplasms |  | Raloxifene | 2.00 | 15758505	17242785	17893378	17261762	15572757	15775269	17595753	17049068	17952589	17440819	16837676	16912660 | 
| MESH:D001943 | Breast Neoplasms |  | Tamoxifen | 2.00 | 19059307	20135344	18425577	19189210	17440819	19084267	20859285	16202921	19288272	15565566	19289846	17893378	19410462	15668708	16873071	19142967	19103187	18351453	16273361	18629630	19487384	19189212	21138602	17242785	19200415	19115204	17261762	19221464	21152245	18855134	19244106	19011961	20390343	18815881	17049068	19155303	18997820	11161223	20005174	20544844	18984771	18821012	16818667	20065188	19066611 | 
| MESH:D002276 | Carcinoid Tumor |  | Doxorubicin | 5.25 | 16051944 | 
| MESH:D018270 | Carcinoma, Ductal, Breast |  | Tamoxifen | 4.87 | 19066611 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Doxorubicin | 3.26 | 16023760	18059187	16234567	17876044 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Tamoxifen | 3.26 | 16924424 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Doxorubicin | 7.33 | 1485588	16201981 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Vinblastine | 7.33 | 1485588 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Doxorubicin | 2.70 | 6189445 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Raloxifene | 10.40 | 17572228 | 
| MESH:D002295 | Carcinoma, Transitional Cell |  | Tamoxifen | 10.40 | 17572228 | 
| MESH:D009202 | Cardiomyopathies |  | Doxorubicin | 3.70 | 17382496	16109756	15792986	16269455	15811867	17308081	16952015	15505089	16278810	16364871	17974986	17329180	16612575	18627295	17928571	17351982	17007740	15476868	17924179	16651473	16242529	17131338	16455267	16731534	17519947 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Doxorubicin | 3.02 | 17334414	16243910 | 
| MESH:D002318 | Cardiovascular Diseases |  | Raloxifene | 3.63 | 15775269 | 
| MESH:D003072 | Cognition Disorders |  | Raloxifene | 4.98 | 15800139 | 
| MESH:D015179 | Colorectal Neoplasms |  | Doxorubicin | 2.98 | 18802399	18259882 | 
| MESH:D015179 | Colorectal Neoplasms |  | Vinblastine | 2.98 | 18802399 | 
| MESH:D003711 | Demyelinating Diseases |  | Tamoxifen | 4.72 | 19031437 | 
| MESH:D003865 | Depressive Disorder, Major |  | Raloxifene | 4.41 | 17474826 | 
| MESH:D003928 | Diabetic Nephropathies |  | Raloxifene | 9.87 | 17451421	17308373	15920148 | 
| MESH:D003928 | Diabetic Nephropathies |  | Tamoxifen | 9.87 | 19279558 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Doxorubicin | 2.50 | 17416283 | 
| MESH:D004362 | Drug Toxicity |  | Doxorubicin | 3.87 | 18602426 | 
| MESH:D004487 | Edema |  | Raloxifene | 3.61 | 15860553 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Raloxifene | 10.36 | 15845917 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Tamoxifen | 10.36 | 19031437 | 
| MESH:D016889 | Endometrial Neoplasms |  | Doxorubicin | 8.13 | 17359293 | 
| MESH:D016889 | Endometrial Neoplasms |  | Tamoxifen | 8.13 | 16202921	19155303	20544844	17893378 | 
| MESH:D004719 | Endomyocardial Fibrosis |  | Doxorubicin | 5.60 | 18037988 | 
| MESH:D005234 | Fatty Liver |  | Raloxifene | 8.94 | 17473493 | 
| MESH:D005234 | Fatty Liver |  | Tamoxifen | 8.94 | 14986274	19224547 | 
| MESH:D052776 | Female Urogenital Diseases |  | Tamoxifen | 3.39 | 16709447 | 
| MESH:D018221 | Fibromatosis, Abdominal |  | Tamoxifen | 4.92 | 14745880 | 
| MESH:D018222 | Fibromatosis, Aggressive |  | Doxorubicin | 12.80 | 19069698 | 
| MESH:D018222 | Fibromatosis, Aggressive |  | Tamoxifen | 12.80 | 19069698 | 
| MESH:D005909 | Glioblastoma |  | Doxorubicin | 3.52 | 17150277 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Doxorubicin | 3.70 | 15692506 | 
| MESH:D006331 | Heart Diseases |  | Doxorubicin | 8.46 | 18674790	16330681	17875725	16707910	16495754	16144979	16244372	17888722	16879835	12587719	18006777	16244371	14766674 | 
| MESH:D006331 | Heart Diseases |  | Raloxifene | 8.46 | 11110106 | 
| MESH:D006333 | Heart Failure |  | Doxorubicin | 3.50 | 17481944 | 
| MESH:D006394 | Hemangiosarcoma |  | Doxorubicin | 4.18 | 15692506 | 
| MESH:D006689 | Hodgkin Disease |  | Doxorubicin | 8.63 | 15147373	18501091	17606976 | 
| MESH:D006689 | Hodgkin Disease |  | Vinblastine | 8.63 | 18501091	18180244 | 
| MESH:D006973 | Hypertension |  | Raloxifene | 2.95 | 17577099	15787275 | 
| MESH:D007249 | Inflammation |  | Tamoxifen | 2.48 | 19457130 | 
| MESH:D007674 | Kidney Diseases |  | Doxorubicin | 3.20 | 15699352	15369732	16775033 | 
| MESH:D007676 | Kidney Failure, Chronic |  | Doxorubicin | 4.44 | 16707910 | 
| MESH:D007680 | Kidney Neoplasms |  | Tamoxifen | 3.27 | 18625569 | 
| MESH:D007889 | Leiomyoma |  | Raloxifene | 4.80 | 16973256 | 
| MESH:D004915 | Leukemia, Erythroblastic, Acute |  | Doxorubicin | 5.60 | 16085563 | 
| MESH:D008064 | Lipidoses |  | Tamoxifen | 3.35 | 15342952	17567588 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Doxorubicin | 2.68 | 16439617	16595196 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tamoxifen | 2.68 | 18564211 | 
| MESH:D008113 | Liver Neoplasms |  | Mitomycin | 5.26 | 15113037 | 
| MESH:D008113 | Liver Neoplasms |  | Tamoxifen | 5.26 | 16684651 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Doxorubicin | 3.17 | 16842330	17085340 | 
| MESH:D008175 | Lung Neoplasms |  | Doxorubicin | 2.65 | 17418594	6189445 | 
| MESH:D008175 | Lung Neoplasms |  | Tamoxifen | 2.65 | 18625569 | 
| MESH:D008223 | Lymphoma |  | Doxorubicin | 3.65 | 16098063 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Doxorubicin | 4.02 | 17654614 | 
| MESH:D016399 | Lymphoma, T-Cell |  | Doxorubicin | 4.93 | 15621674 | 
| MESH:D015674 | Mammary Neoplasms, Animal |  | Tamoxifen | 4.15 | 19428831 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Doxorubicin | 6.70 | 15458769 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Tamoxifen | 6.70 | 19196722	11731420	19196723	14580682	16827153 | 
| MESH:D020149 | Manganese Poisoning |  | Tamoxifen | 4.99 | 19453300 | 
| MESH:D008545 | Melanoma |  | Doxorubicin | 5.49 | 16827129 | 
| MESH:D008545 | Melanoma |  | Tamoxifen | 5.49 | 12393984	19393235 | 
| MESH:D008545 | Melanoma |  | Vinblastine | 5.49 | 18332650	15577320	15577323	18176117	16432458	12374674	16248763	17761969	16809738	18505091 | 
| MESH:D018328 | Melanoma, Amelanotic |  | Tamoxifen | 4.58 | 15990972 | 
| MESH:D008654 | Mesothelioma |  | Doxorubicin | 3.15 | 17638057 | 
| MESH:D028361 | Mitochondrial Diseases |  | Doxorubicin | 4.78 | 15792986 | 
| MESH:D018200 | Mixed Tumor, Mullerian |  | Raloxifene | 6.00 | 15863610 | 
| MESH:D052016 | Mucositis |  | Doxorubicin | 5.19 | 17415656 | 
| MESH:D009101 | Multiple Myeloma |  | Raloxifene | 3.63 | 16497877 | 
| MESH:D009203 | Myocardial Infarction |  | Doxorubicin | 3.04 | 15857846	19429709 | 
| MESH:D009232 | Myxoma |  | Raloxifene | 6.00 | 16343187 | 
| MESH:D009362 | Neoplasm Metastasis |  | Doxorubicin | 6.18 | 18259882 | 
| MESH:D009362 | Neoplasm Metastasis |  | Tamoxifen | 6.18 | 19393235 | 
| MESH:D009364 | Neoplasm Recurrence, Local |  | Tamoxifen | 2.59 | 19410462 | 
| MESH:D009376 | Neoplasms, Hormone-Dependent |  | Tamoxifen | 4.44 | 19189210	19196722	19200415 | 
| MESH:D009401 | Nephrosis |  | Doxorubicin | 5.13 | 16899518	16636307 | 
| MESH:D009404 | Nephrotic Syndrome |  | Doxorubicin | 4.25 | 15640375	16889571 | 
| MESH:D009447 | Neuroblastoma |  | Doxorubicin | 3.39 | 15555623 | 
| MESH:D009503 | Neutropenia |  | Vinblastine | 4.87 | 17378895 | 
| MESH:D010024 | Osteoporosis |  | Raloxifene | 3.55 | 15775268	17882678	19059307 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | Raloxifene | 4.53 | 17823083	17893378	15579764	15758505 | 
| MESH:D012516 | Osteosarcoma |  | Doxorubicin | 4.34 | 15930896 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Mitomycin | 3.53 | 15113037 | 
| MESH:D003557 | Phyllodes Tumor |  | Doxorubicin | 5.60 | 17983394 | 
| MESH:D010997 | Pleural Neoplasms |  | Doxorubicin | 5.60 | 17638057 | 
| MESH:D011471 | Prostatic Neoplasms |  | Doxorubicin | 2.60 | 15897917	15749863	18437689	16868541	16729912	16888761 | 
| MESH:D011471 | Prostatic Neoplasms |  | Raloxifene | 2.60 | 15731164	16220300	16536755 | 
| MESH:D011471 | Prostatic Neoplasms |  | Tamoxifen | 2.60 | 15067354 | 
| MESH:D011693 | Purpura |  | Raloxifene | 6.00 | 15770314 | 
| MESH:D051437 | Renal Insufficiency |  | Doxorubicin | 4.58 | 17922066 | 
| MESH:D012509 | Sarcoma |  | Doxorubicin | 4.25 | 17203757	16767912	18313854	15625365	15675481	17710206 | 
| MESH:D012512 | Sarcoma, Ewing's |  | Doxorubicin | 4.57 | 14601052	16326096 | 
| MESH:D012514 | Sarcoma, Kaposi |  | Doxorubicin | 5.19 | 17846226 | 
| MESH:D012878 | Skin Neoplasms |  | Doxorubicin | 3.06 | 15692506 | 
| MESH:D012983 | Soft Tissue Neoplasms |  | Doxorubicin | 4.93 | 17203757	15625365	16767912 | 
| MESH:D013088 | Spermatocele |  | Tamoxifen | 4.74 | 16709447 | 
| MESH:D013119 | Spinal Cord Injuries |  | Tamoxifen | 4.43 | 19457130 | 
| MESH:D020521 | Stroke |  | Raloxifene | 4.04 | 16837676 | 
| MESH:D013964 | Thyroid Neoplasms |  | Doxorubicin | 3.58 | 17909728	16010429 | 
| MESH:D013978 | Tibial Fractures |  | Raloxifene | 5.65 | 19048282 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Doxorubicin | 8.97 | 17653716 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Raloxifene | 8.97 | 17572228 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Tamoxifen | 8.97 | 16712894	8653321	17572228 | 
| MESH:D014625 | Vaginal Neoplasms |  | Vinblastine | 5.40 | 15577323 | 
| MESH:D054556 | Venous Thromboembolism |  | Raloxifene | 5.65 | 16837676 | 
| MESH:D018487 | Ventricular Dysfunction, Left |  | Doxorubicin | 4.58 | 17678736	17638931	17334414	16364871 | 
| MESH:D014846 | Vulvar Neoplasms |  | Raloxifene | 6.00 | 16343187 |